Abstract
Several studies show that treatment with metformin, a drug used for the treatment of type 2 diabetes, reduces the risk of developing cancer. Classically, metformin acts in the liver decreasing glycemia and improving secondary hyperinsulinemia. Such effects could also impact tumorigenesis, since hyperinsulinemia has been associated with poor prognosis in several types of cancer, such as br…